Hemodynamic and metabolic effects of terlipressin in patients with cirrhosis receiving a nonselectiveβ-blocker
✍ Scribed by Florence Vachiery; Richard Moreau; Adrian Gadano; Song Yang; Phillippe Sogni; Antoine Hadengue; Stephane Cailmail; Thierry Soupison; Didier Lebrec
- Publisher
- Springer US
- Year
- 1996
- Tongue
- English
- Weight
- 523 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0163-2116
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A decrease in plasma noradrenalin-a reflection of sympathetic nervous system activity-by clonidine, a centrally acting u2-agoni8t, could reduce the hyperdynamic circulation oherved in cirrhosis and may thereby decregse portal hypertension. Plasma noradrenaline oonceatration and plasma renin activity
The effects of dopamine on kidney function have not been elucidated in patients with cirrhosis. Moreover, although increased portal pressure has been observed with supradopaminergic doses of dopamine in these patients, the splanchnic hemodynamic effects of low doses of dopamine have not been previou
The present double-blind study was aimed at investigating the hemodynamic and humoral effects of somatostatin or placebo in patients with cirrhosis. Patients were randomly assigned to receive either an injection of 250 pg of somatostatin followed by a constant infusion of somatostatin at 250 pg/h (n
## Abstract A new calcium channel blocker, niludipine, was administered intravenously to nine patients with coronary artery disease in order to investigate its effects on left ventricular systolic and diastolic function, coronary sinus blood flow, and myocardial lactate metabolism. Coronary sinus p